Earlier this month, the Chinese government tightened rules for exports of certain medical products used to combat COVID-19 in response to high-profile complaints about their quality. In light of these new requirements, exporters and importers of these goods can expect that the customs process will be delayed.
China Market Intelligence
On July 31, US-China Business Council (USCBC) President Craig Allen testified before the US-China Economic Security Review Commission (USCC) on US companies’ access, risks, and opportunities in China’s health market.
Draft amendments make some progress in strengthening China’s intellectual property rights (IPR) system, including by increasing penalties, extending patent term for designs, and adding patent term restoration for innovative pharmaceuticals.
On September 7, the 13th National People’s Congress Standing Committee (NPCSC), China’s constitutional authority, released its five-year legislative plan, outlining and prioritizing major legislative tasks into three classes that, in princi
China’s regulators recently released the first drug traceability proposal since China suspended its previous system in 2016 because of a number of
The Shanghai Free Trade Zone (FTZ) Market Regulatory Authority (MRA) recently issued a penalty decision against a foreign medical product distributor for false promotion under the Anti-unfair Competition Law (AUCL), the revised version of which came into effect January 1.
China has implemented new rules setting requirements on the storage, use, and flow of scientific data. Although intended to strengthen data security and promote data sharing, the measures could affect companies’ university partnerships and R&D centers in the pharmaceutical, automotive and tech industries.
US companies now have stronger recourse against Chinese businesses that claim Chinese law as a protection for unfair practices.
China’s National Development and Reform Commission (NDRC) recently announced its 2018 priorities for pricing investigations under the anti-monopoly law (AML), listing key industries in which it says price-fixing tactics